Advertisement

Angiotensin II Induced Hypertension Chemotherapy (IHC) for Advanced Gastric Carcinoma

  • Haruhiko Sato
  • Katsuo Sugiyama
  • Keiichi Ishizuka
  • Masahiko Hoshi
  • Masanobu Urushiyama
  • Maroh Suzuki
Conference paper

Abstract

Under angiotensin 11 (A II) induced hypertension in which the mean arterial blood pressure did not exceed 150 mmHg, blood flow in tumor tissue increased selectively, while not in normal tissues. A II induced hypertension chemotherapy(IHC) has been carried out since 1978. Two randomized controlled trials, using a combination regimen of ADM,5-FU and MMC for advanced gastric carcinoma, showed significant augmentation of anti-tumor effects without increase of side effects. Surgical and pathological down-staging was observed in stage IV cancer patients. Based on the functional characteristics of tumor microcirculation, IHC which is a system of selective enhancement of drug delivery to tumor, will be useful for patients with any malignant tumors.

Key Words

induced hypertension chemotherapy (IHC) selective enhancement of drug delivery tumor microcirculation gastric carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Algire GH, Legallais FY, Anderson BF. (1954) Vascular reaction of normal and malignant tissue in vivo. VI.The role of hypotension in the action of components of podophyllin on transplanted sarcoma. J. Natl Cancer Inst 14: 879–893.PubMedGoogle Scholar
  2. 2.
    Gullino PM, Grantham FH.(1962) Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rats tumors. J Natl Cancer Inst 28: 211–229.PubMedGoogle Scholar
  3. 3.
    Kjartansson I.(1976) Tumor microcirculation. An experimental study in rat with a comparison of different methods for estimation of tumor blood flow. Acta Chirurg Scand (suppl 471): 5–74.Google Scholar
  4. 4.
    Edlich RF, Rogers U, DeShaso CV Jr, Aust JB.(1966) Effect of vasoactive drugs on tissue blood flow in the hamster melanoma. Cancer Res 26:1420–1424.PubMedGoogle Scholar
  5. 5.
    Burton MA, Gray BN, Self GW, Heggie JC, Townsend PS. (1985) Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II. Cancer Res 45: 5390–5393.PubMedGoogle Scholar
  6. 6.
    Chaplin DJ. (1991) The effect of therapy on tumor vascular function. Int J Radiat Biol 60:311–325.PubMedCrossRefGoogle Scholar
  7. 7.
    Suzuki M, Hori K, Abe I, Saito S. and Sato H. (1978) Characteristic blood circulation in tumor tissue with reference to chemotherapy. Cancer and chemotherapy 5(suppl) : 77–80.Google Scholar
  8. 8.
    Suzuki M, Hori K, Abe I, Saito S.and Sato H. (1981) A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67: 663–669.PubMedGoogle Scholar
  9. 9.
    Sato H, Sato K, Sato Y, Asamura M, Kanamaru R, Sugiyama Z, Kitahara T, Wakui A, Suzuki M, Hori K, Abe I, Saito S. and Sato H. (1981) Induced hypertension chemotherapy of cancer patients by selective enhancement of drug delivery to tumor tissue with angiotensin II. Sci Rep Res Inst, Tokoku Cniv Ser-C 28: 32–44.Google Scholar
  10. 10.
    Sato H, Sato K, Sato Y, Mimata Y, Asamura M, Kanamaru R, Wakui A, Suzuki M and Sato H. (1980) Clinical study on selective enhancement of drug delivery by angiotensin II in cancer chemotherapy. In: Metastasis, clinical and experimental aspect. Hellmann K, Hillgard P. and Eccles S.(eds). Martinus Nijhoff Publishers, The Hague, pp388–394.Google Scholar
  11. 11.
    Sato H, Sato K, Sato Y, Asamura M, Kanamaru R, Mimata Y. and Wakui A. (1981) Clinical cancer chemotherapy based on the experimental findings of selective enhancement of drug delivery to tumor tissue by angiotensin II. Jpn J Cancer Chemother 8(suppl) : 91–100.Google Scholar
  12. 12.
    Suzuki M, Hori K, Abe I, Saito S. and Sato H.(1984) Functional characteristics of the microcirculation in tumors. Cancer Metastasis Rev 3:115–126.PubMedCrossRefGoogle Scholar
  13. 13.
    Suzuki M, Hori K, Saito S.Tanda S, Abe I. Sato H. and Sato H. (1989) Functional characteristics of tumor vesse1s:Se1ective increase in tumor blood flow. Sci Rep Res Inst,Tokoku Univ Ser-C 36: 37–45.Google Scholar
  14. 14.
    Hoshi M. (1988) Increase of blood flow in human tumors under angiotensin II induced hypertension. Kosankinbyo Kenkyusyo Zasshi 40: 41–52.Google Scholar
  15. 15.
    Ishizuka K. (1993) DDS(in press).Google Scholar
  16. 16.
    Hoshi M, Abe I, Sugiyama K, Ishizuka K, Sato H, Urushiyama M. and Wakui A. (1991) Selective enhancement of the image intensity of contrast media on dynamic CT under angiotensin II human(TY-10721) induced hypertension state. DDS 6: 109–116.CrossRefGoogle Scholar
  17. 17.
    Sato H, Hoshi M, Urushiyama M, Sugiyama K. and Wakui A. (1989) Angiotensin II induced hypertension chemotherapy(IHC) and dose intensity (DI).DDS 4:105–110.CrossRefGoogle Scholar
  18. 18.
    Urushiyama M. (1990) Growth inhibition of micrometastases in the liver and angiotensin II induced hypertension chemotherapy (IHC).Kosankinbyo Kenkyusho Zasshi 42:133–144.Google Scholar
  19. 19.
    Sugiyama K. (1990) Selective enhancement of drug delivery to the peritoneal tumor and angiotensin II induced hypertension. Kosankinbyo Kenkyusho Zasshi 42: 145–159.Google Scholar
  20. 20.
    Hori K, Suzuki, Tanda S. and Saito S. (1990) In vivo analysis of tumor vascularization in the rat. Jpn J Cancer Res 81:279–288.PubMedCrossRefGoogle Scholar
  21. 21.
    Hori K, Suzuki M, Tanda S.and Saito S. (1991) Characterization of heterogeneous distribution of tumor blood flow in the rat. Jpn J Cancer Res 82: 109–117.PubMedCrossRefGoogle Scholar
  22. 22.
    Hori K, Suzuki M, Tanda S, Saito S.and Zang QH. (1993) Functional characterization of developing tumor vascular system and drug delivery (review). Int J Oncol 2:289–296.PubMedGoogle Scholar
  23. 23.
    Sato H, Hoshi M, Wakui A. (1986) Clinical study on angiotensin induced hypertension chemotherapy (IHC). Jpn J Cancer Chemother 13:1439–1447.Google Scholar
  24. 24.
    Sato H, Wakui A, Hoshi M, Kurihara M, Yokoyama M. and Shimizu H.(1991) Randomized controlled trial of induced hypertension chemotherapy (IHC) using angiotensin II human(TY-10721) in advanced gastric carcinoma. (TY-10721 IHC Study Group Report). Jpn J Cancer Chemother 18:451–460.Google Scholar

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Haruhiko Sato
    • 1
  • Katsuo Sugiyama
    • 1
  • Keiichi Ishizuka
    • 1
  • Masahiko Hoshi
    • 1
  • Masanobu Urushiyama
    • 1
  • Maroh Suzuki
    • 1
  1. 1.Department of Clinical Cancer Chemotherapy and Department of Experimental Oncology, The Research Institute for Cancer and TuberculosisTohoku UniversitySendai, 980Japan

Personalised recommendations